3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
19
Active not recruiting
13
Recruiting
11
Terminated
7
Unknown
3
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Adenocarcinoma
1
Interventions
Carboplatin
126
Cisplatin
125
Drug Therapy
104
Bevacizumab
98
Oxaliplatin
97
Capecitabine
96
Radiotherapy
94
Gemcitabine
87
Paclitaxel
85
tislelizumab
84
Cyclophosphamide
83
Specimen Handling
80
pembrolizumab
76
toripalimab
67
Magnetic Resonance Spectroscopy
63
Injections
62
Fluorouracil
62
sintilimab
57
anlotinib
53
Surgical Procedures, Operative
50
130-nm albumin-bound paclitaxel
50
Docetaxel
49
fludarabine
46
Pemetrexed
45
Standard of Care
43
venetoclax
42
Leucovorin
42
Biopsy
42
Irinotecan
41
lenvatinib
40
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Interventional
×
luprolide acetate gel depot
×
Clear all
NCT06855589
2025-03-04
PCS-XII
Charles LeMoyne Hospital
Phase 3
Not yet recruiting
400 enrolled